Post-Intensive Care Syndrome in COVID-19 versus Non-COVID-19 Critical Illness Survivors: More Similar than Not?

Matthew R Baldwin¹, George L Anesi^{2

3}

Affiliations

¹ Division of Pulmonary, Allergy, and Critical Care Columbia University Vagelos College of Physicians and Surgeons New York, New York.
² Division of Pulmonary, Allergy, and Critical Care.
³ Palliative and Advanced Illness Research (PAIR) Center University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania.

Editorial

Matthew R Baldwin et al. Am J Respir Crit Care Med. 2022.

. 2022 May 15;205(10):1133-1135.

doi: 10.1164/rccm.202202-0396ED.

Matthew R Baldwin¹, George L Anesi^{2

3}

¹ Division of Pulmonary, Allergy, and Critical Care Columbia University Vagelos College of Physicians and Surgeons New York, New York.
² Division of Pulmonary, Allergy, and Critical Care.
³ Palliative and Advanced Illness Research (PAIR) Center University of Pennsylvania Perelman School of Medicine Philadelphia, Pennsylvania.

No abstract available

Comment on

Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non-COVID-19 Critical Illness.
Hodgson CL, Higgins AM, Bailey MJ, Mather AM, Beach L, Bellomo R, Bissett B, Boden IJ, Bradley S, Burrell A, Cooper DJ, Fulcher BJ, Haines KJ, Hodgson IT, Hopkins J, Jones AYM, Lane S, Lawrence D, van der Lee L, Liacos J, Linke NJ, Gomes LM, Nickels M, Ntoumenopoulos G, Myles PS, Patman S, Paton M, Pound G, Rai S, Rix A, Rollinson TC, Tipping CJ, Thomas P, Trapani T, Udy AA, Whitehead C, Anderson S, Neto AS; COVID-Recovery Study Investigators and the ANZICS Clinical Trials Group. Hodgson CL, et al. Am J Respir Crit Care Med. 2022 May 15;205(10):1159-1168. doi: 10.1164/rccm.202110-2335OC. Am J Respir Crit Care Med. 2022. PMID: 35258437 Free PMC article.

1. Gattinoni L, Chiumello D, Caironi P, Busana M, Romitti F, Brazzi L, et al. COVID-19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med . 2020;46:1099–1102. - PMC - PubMed
1. Sinha P, Matthay MA, Calfee CS. Is a “cytokine storm” relevant to COVID-19? JAMA Intern Med . 2020;180:1152–1154. - PubMed
1. Leisman DE, Ronner L, Pinotti R, Taylor MD, Sinha P, Calfee CS, et al. Cytokine elevation in severe and critical COVID-19: a rapid systematic review, meta-analysis, and comparison with other inflammatory syndromes. Lancet Respir Med . 2020;8:1233–1244. - PMC - PubMed
1. Fan E, Beitler JR, Brochard L, Calfee CS, Ferguson ND, Slutsky AS, et al. COVID-19-associated acute respiratory distress syndrome: is a different approach to management warranted? Lancet Respir Med . 2020;8:816–821. - PMC - PubMed
1. Sinha P, Furfaro D, Cummings MJ, Abrams D, Delucchi K, Maddali MV, et al. Latent class analysis reveals COVID-19-related acute respiratory distress syndrome subgroups with differential responses to corticosteroids. Am J Respir Crit Care Med . 2021;204:1274–1285. - PMC - PubMed